Showing posts with label Cancer vaccine. Show all posts
Showing posts with label Cancer vaccine. Show all posts

Tuesday, June 9, 2015

Attend IBC's Immuno-Oncology Conference in Alexandria, VA for FREE as a Guest Blogger


Earn a complimentary all-access pass to Immuno-Oncology conference by serving as a Guest Blogger at the event. As a Guest Blogger, you’ll have access to the Immuno-Oncology event’s comprehensive agenda attracting the best insights from around the world, right in Alexandria, VA in September.





Immuno-Oncology Conference
September 30-October 1, 2015
Hilton Alexandria Mark Center, Alexandria, VA


We are looking for an industry expert to be the face of the IBC's Immuno-Oncology social media campaign. The premise is to provide immuno-oncology and cancer immunotherapies - related articles, whitepapers, and overall original content.
Some of the topics of the conference are: 
  • cancer vaccines;
  • T-cell therapy;
  • agnostic antibodies;
  • combination therapies and others.

What You get:
  • FREE pass to IBC's Immuno-Oncology conference (valued up to $1,999);
  • Extensive social learning activities;
  • Exclusive access to a networking community in the industry of your interest!
You also have a chance to GAIN exposure through our five health related-blogs with over 2000 unique visitors monthly each and more than 20 healthcare LinkedIn groups.

Learn more about the IBC's Immuno-Oncology conference event by visiting the website:

Interested and want to learn more about this opportunity please contact Amanda Caterina at acaterina@iirusa.com or directly at 646-895-7339.

We hope to have you join us in Alexandria!

Cheers,
The IBC's Immuno-Oncology Team

@ibcusa
#Immuno15
Future of Biopharma Blog http://futurebiopharma.blogspot.com/


Share this article with your social network, just click below to share now!


Friday, May 15, 2015

Last Chance to Save Up To $550 off Immuno-Oncology

As research in cancer immunotherapies continues to rapidly evolve, it is critical to separate the real opportunities from the hype. There has been great progress with checkpoint inhibitors, CAR-T and T-Cell therapies, cancer vaccines, agnostic antibodies, and combination therapies.

IBC's Immuno-Oncology provides the critical insights and strategies you need to improve response rates, efficacy, and get closer to a cure!

Download the full agenda for complete session and speaker information here:

Immuno-Oncology
Advancing the Next Generation of Cancer Immunotherapies
September 30 – October 1, 2015
Hilton Alexandria Mark Center, Alexandria, VA

Visit the website for more details: http://bit.ly/1A4NPY2

Don't miss out on maximum savings for IBC's Immuno-Oncology!

Register by May 15 to Save up to $550 off the standard rates: http://bit.ly/1A4NPY2

Register today and explore the latest advances in Immuno-Oncology to:
-          Design next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
-          Develop a successful combination therapy strategy by gaining insights from global leaders on effective combinations
-          Improve the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies

Best,
The Immuno-Oncology Team 2015
@ibcusa
facebook.com/ibclifesciences

www.ibclifesciences.com/ImmunoOncology


Share this article with your social network, just click below to share now!